Senior Associate, Investments

Roivant is a biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant advances its pipeline by creating nimble subsidiaries or “Vants” to develop and commercialize medicines and technologies. Since its inception in 2014, Roivant has achieved the following critical milestones in support of its vision: built over 20 Vants;

12 consecutive positive Phase 3 trials; 8 FDA approvals; 5 successful IPOs; >$6B in capital raised; >$10B in global pharma partnerships and proceeds; and continued pipeline expansion across various modalities and therapeutic areas through in‑licensing and acquisition of novel product candidates and technology platforms. In addition to a robust clinical stage pipeline, Roivant also incubates discovery‑stage companies and health technology startups complementary to its biopharmaceutical business.

To learn more about our story and company culture, please visit us at

This position is a unique role among biotechnology companies as it more closely resembles a buy‑side investor role, rather than a conventional business development position in a biopharmaceutical company. In this role, you will be responsible for building the scientific/clinical rationale and investment case for novel drug development ideas and drug acquisition targets. Because it involves the sourcing, assessment, and in‑licensing of new assets and new company creation, this position is essential to achieving Roivant’s growth targets and company mission.

• Understand the broad biotech/pharmaceutical market landscape and clinical development process for marketing approval
• Review, aggregate, analyze and monitor pharmaceutical development databases and market research reports
• Help develop and grow a robust pipeline of targets by searching publicly available databases and online resources for novel drug development ideas
• Create and maintain an internal database of potential acquisition candidates
• Conduct in‑depth scientific, clinical and market research and financial modeling to support recommendations
• Help inform the investment thesis through rigorous modeling of potential commercial launch trajectories and revenue projections
• Construct persuasive investment theses in the form of PowerPoint presentations and supporting Excel models
• Communicate theses directly to senior management advocating for specific drug development projects
• Partner with senior members of the Investment group to assist with all elements of transactions on new investments through closing, including due diligence, valuation, deal structuring, and negotiations

• Familiarity with the major scientific and medical aspects of drug development
• Strong scientific and analytical skills
• Exceptional attention to detail
• Experience writing research reports and delivering presentations that integrate multiple data sources
• Proficiency with MS Office suite, including functions and pivot tables (Word, Excel, and PowerPoint)
• Experience using multiple pharmaceutical competitive intelligence databases
• Excellent written and verbal communication skills
• A minimum of two to three years of buy‑side healthcare investing experience, primarily focused on therapeutics required
• Bachelor’s degree required (preferably in science); MD or PhD strongly preferred

Base salary for this role will be determined during the interview process and will vary based on multiple factors, including but not limited to prior experience, relevant expertise, current business needs, and market conditions. The expected base salary for the role will generally be between $160,000-$230,000 per year at the commencement of employment, but the final salary offered may be outside this range based on individual circumstances and business and market conditions.

Base salary if hired is only part of the total compensation package, which, depending on the position, may also include other components such as discretionary bonuses, equity, and Company‑sponsored benefit programs.

This position is at‑will and Roivant reserves the right to modify base salary (as well as any other discretionary…